Spero Therapeutics
SPRO
#10353
Rank
S$55.76 M
Marketcap
S$0.96
Share price
-10.20%
Change (1 day)
-69.24%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2026 (TTM): S$8.33 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are S$42.96 Million. In 2025 the company made an earning of S$9.23 Million, an increase over its 2024 earnings that were of -S$93.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$8.33 M-9.72%
2025 S$9.23 M-109.88%
2024 -S$93.51 Million-360.42%
2023 S$35.9 M-163.53%
2022 -S$56.52 Million-50.14%
2021 -S$0.12 Billion11.06%
2020 -S$0.11 Billion25.15%
2019 -S$81.55 Million47.68%
2018 -S$55.22 Million5.61%
2017 -S$52.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
IBM
IBM
S$13.55 B 158,792.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
S$2.55 B 29,800.18%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
S$8.29 M-2.80%๐Ÿ‡บ๐Ÿ‡ธ USA